home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Accelerating Radiopharmaceutical Therapy with Translational Tools

 
  October 17, 2025  
     
 
Xtalks, Online
2025-11-14


Radioligand therapy development is progressing rapidly, but success depends on selecting the right preclinical models, optimal study designs and translational strategies. Many programs stall due to gaps in model relevance, study design or isotopic selection. Join this webinar to explore how early, informed decisions can de-risk development, validate therapeutic targets and support clinical translation, from discovery through IND.

This webinar is designed for researchers, drug developers and translational scientists focused on radioligand therapy and other targeted therapeutic approaches. It will highlight how the integration of radiochemistry, robust preclinical models and well-designed studies can generate reliable and reproducible data to guide smarter development decisions.

Join the featured speakers to explore:

How to choose preclinical tumor models that reflect relevant biology and target expression
Radiochemistry considerations, including isotope selection and labeling strategies
Best practices for designing preclinical studies that address key translational questions
How to generate decision-ready data that supports clinical translation
A case study from glioblastoma research, showing how a combination of FACs analysis and advanced [¹⁷⁷Lu]FAP-2886 imaging can be used to determine FAP targeting and therapeutic potential in the U87MG model

Register for this webinar to see how imaging-based readouts can transform radiopharmaceutical therapy, reduce risk and bring promising therapies closer to patients.

Keywords: ADCs, CNS, CRO, Drug Development, Drug Discovery, Oncology, Pre-Clinical, Preclinical Models, Radioligands, Radiopharmaceuticals, Radiotherapy, Small Molecule, Therapeutic Areas, Translational Research, Tumor
 
 
Organized by: Xtalks
Invited Speakers: Mike Batey, Senior Director, SMS Discovery, Perceptive
Julian Goggi, PhD, Director, Discovery Research, Perceptive
 
Deadline for Abstracts: 2025-11-14
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2025 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.